Wang Suo Jin - Net Worth and Insider Trading
Wang Suo Jin Net Worth
The estimated net worth of Wang Suo Jin is at least $1 Million dollars as of 2025-07-25. Wang Suo Jin is the Executives of Jinling Pharmaceutical Co Ltd and owns about 182,500 shares of Jinling Pharmaceutical Co Ltd (SZSE:000919) stock worth over $1 Million. Details can be seen in Wang Suo Jin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wang Suo Jin has not made any transactions after 2017-07-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Wang Suo Jin
Wang Suo Jin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wang Suo Jin owns 1 companies in total, including Jinling Pharmaceutical Co Ltd (SZSE:000919) .
Click here to see the complete history of Wang Suo Jin’s form 4 insider trades.
Insider Ownership Summary of Wang Suo Jin
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
SZSE:000919 | Jinling Pharmaceutical Co Ltd | 2017-07-06 | Executives |
Wang Suo Jin Latest Holdings Summary
Wang Suo Jin currently owns a total of 1 stock. Wang Suo Jin owns 182,500 shares of Jinling Pharmaceutical Co Ltd (SZSE:000919) as of July 6, 2017, with a value of $1 Million.
Latest Holdings of Wang Suo Jin
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SZSE:000919 | Jinling Pharmaceutical Co Ltd | 2017-07-06 | 182,500 | 7.18 | 1,310,350 |
Holding Weightings of Wang Suo Jin
Wang Suo Jin Form 4 Trading Tracker
According to the SEC Form 4 filings, Wang Suo Jin has made a total of 0 transactions in Jinling Pharmaceutical Co Ltd (SZSE:000919) over the past 5 years. The most-recent trade in Jinling Pharmaceutical Co Ltd is the acquisition of 14,600 shares on July 6, 2017, which cost Wang Suo Jin around $159,286.
Insider Trading History of Wang Suo Jin
- 1
Wang Suo Jin Trading Performance
GuruFocus tracks the stock performance after each of Wang Suo Jin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wang Suo Jin is 1.67%. GuruFocus also compares Wang Suo Jin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wang Suo Jin within 3 months outperforms 5 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wang Suo Jin's insider trading performs compared to the benchmark.
Performance of Wang Suo Jin
Wang Suo Jin Ownership Network
Ownership Network List of Wang Suo Jin
Ownership Network Relation of Wang Suo Jin

Wang Suo Jin Owned Company Details
What does Jinling Pharmaceutical Co Ltd do?
Who are the key executives at Jinling Pharmaceutical Co Ltd?
Wang Suo Jin is the Executives of Jinling Pharmaceutical Co Ltd. Other key executives at Jinling Pharmaceutical Co Ltd include Executives Jia Ming Yi , Executives Li Quan , and Executives Chen Sheng .
Jinling Pharmaceutical Co Ltd (SZSE:000919) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Jinling Pharmaceutical Co Ltd (SZSE:000919) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Jinling Pharmaceutical Co Ltd (SZSE:000919) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Jinling Pharmaceutical Co Ltd (SZSE:000919)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jinling Pharmaceutical Co Ltd Insider Transactions
Wang Suo Jin Mailing Address
Above is the net worth, insider trading, and ownership report for Wang Suo Jin. Currently GuruFocus does not have mailing address information for Wang Suo Jin.